Optima Health plc (AIM:OPT)
London · Delayed Price · Currency is GBP · Price in GBX 221.00
+9.50 (4.49%)
At close: Jul 27, 2026
Optima Health Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 8.27 | 14.8 | 21.1 | 12.73 | 6.9 |
Cash & Short-Term Investments | 8.27 | 14.8 | 21.1 | 12.73 | 6.9 |
Cash Growth | -44.14% | -29.86% | 65.76% | 84.34% | - |
Accounts Receivable | 23.53 | 18.99 | 17.51 | 19.71 | 13.75 |
Inventory | 0.09 | 0.1 | 0.06 | 0.16 | 0.05 |
Other Current Assets | - | 0.17 | - | 0.27 | - |
Total Current Assets | 31.89 | 34.05 | 38.67 | 32.87 | 20.7 |
Net Property, Plant & Equipment | 9.44 | 7.33 | 4.68 | 6.99 | 4.64 |
Other Intangible Assets | 180.02 | 176.68 | 179.83 | 185.33 | 167.22 |
Other Long-Term Assets | 0.08 | 0.08 | 0.08 | 0.08 | - |
Total Assets | 221.43 | 218.14 | 223.26 | 225.27 | 192.56 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 15.7 | 11.86 | 22.32 | 21.8 | 15.38 |
Short-Term Debt | - | - | 55.08 | 54.1 | 31.68 |
Current Portion of Leases | 0.95 | 0.83 | 1.7 | 2.15 | 0.58 |
Other Current Liabilities | 0.85 | - | 0.06 | - | 0.91 |
Total Current Liabilities | 17.5 | 12.69 | 79.16 | 78.05 | 48.54 |
Long-Term Debt | 13 | 17 | - | - | - |
Long-Term Leases | 5.45 | 3.39 | 0.7 | 1.62 | 1.81 |
Other Long-Term Liabilities | 16.03 | 16.95 | 15.78 | 17.58 | 15.91 |
Total Long-Term Liabilities | 34.48 | 37.34 | 16.48 | 19.19 | 17.71 |
Total Liabilities | 51.97 | 50.02 | 95.64 | 97.24 | 66.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.89 | 0.89 | - | - | - |
Additional Paid-in Capital | 165.4 | 165.4 | 127.47 | 127.32 | 126.5 |
Accumulated Other Comprehensive Income | 0.17 | 0.04 | - | - | - |
Retained Earnings | 3 | 1.8 | 0.15 | 0.71 | -0.19 |
Shareholders' Equity | 169.45 | 168.12 | 127.62 | 128.03 | 126.31 |
Total Liabilities & Equity | 221.43 | 218.14 | 223.26 | 225.27 | 192.56 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 19.4 | 21.21 | 57.48 | 57.87 | 34.06 |
Net Cash (Debt) | -11.13 | -6.42 | -36.38 | -45.14 | -27.16 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.12 | -0.13 | -34618.46 | -48800.00 | -271550.00 |
Book Value | 169.45 | 168.12 | 127.62 | 128.03 | 126.31 |
Book Value Per Share | 1.85 | 3.27 | 121425.00 | 138410.00 | 1263110.00 |
Tangible Book Value | -10.56 | -8.56 | -52.21 | -57.3 | -40.91 |
Tangible Book Value Per Share | -0.12 | -0.17 | -49678.40 | -61942.70 | -409090.00 |